Tuesday April 20, 2021
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International West
    • |COVID-19 Therapeutic Development & Production
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell/Gene Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

Multimedia

White Papers

CHO Cell Culture Media & Feeds

Crude Sample Analysis in Process Development: Time and Cost Savings

Expanding Applications in Downstream Biologics Characterization: Stability, Formulations and Aggregation...

All White Papers

Webinars

Virus-Like Particle Production in Insect Cells Using the Baculovirus Expression System: Addressing Challenges across the Workflow

Increase Efficiency in Your Manufacturing With the Right Buffer Management Strategy

Formulation and Characterization Strategies for Gene Therapies

All Webinars

Podcasts

Podcast: Thermo Fisher on aseptic manufacturing in the time of COVID

Podcast: Content is king in bioprocessing and beyond

Podcast: Industry veteran moves to Lykan Bioscience, and this time its personal!

All Podcasts

Posters

Evaluation Of a New Glucose Control Strategy Using CITSens Bio APC (Automated Process Control) for CHO Fed-Batch Application

High Productivity and Process Economy in GxP Applications with the Octet™ Platform

Accelerate Cell and Gene Therapy Development and Manufacturing with Fully Integrated Closed CAR-T Cell...

All Posters

BPI Theater

Manufacture of CRISPR RNPs for Clinical Use

Technology Integrators in Cell and Gene Therapy: Powering Innovation

Development of an Advanced Gene Therapy Platform

All Theater

Author Audio

December 2014 Issue Author Insights

November 2014 Issue Author Insights

October 2014 Issue Author Insights

All Author Audio

Editor’s Choice

  • BioProcess Insider

    Roche secures space at Novartis plant as COVID drives Actemra demand

  • BioProcess Insider

    Resilience adds CDMO Ology to growing manufacturing footprint

  • Sponsored Content

    Ask the Expert: High-Yield mRNA Processing — From Plasmid to Highly Purified Product

  • BioProcess Insider

    Catalent: ‘Dedicated Moderna line frees space for our non-COVID customers’

  • BioProcess Insider

    BARDA to give Emergent another $23m for tech after J&J jab mix-up

  • Sponsored Content

    Rapid Development of Viral Vector Production Processes: Iterative Parameter Optimization

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @Dan5tanton: In the latest example of pandemic-related collaboration, @Novartis is prepping to make the drug substance for Roche… https://t.co/IpIbSP7F1c 5 days ago
  • Tweet Avatar RT @Dan5tanton: As part of a “difficult decision” to halt its biosimilars programs in China, Pfizer is offloading its single-use bi… https://t.co/vsE7WAknKd 1 month ago
  • Tweet Avatar RT @Dan5tanton: Thermo Fisher’s $600 million CAPEX has got the trade press salivating. But similar statements, expansions underway,… https://t.co/5xHNdfJwRw 1 month ago
  • Tweet Avatar RT @Dan5tanton: Calls for standardization to boost manufacturing agility by executives from Novavax, Fujifilm, and Biocon after a C… https://t.co/UJO2CH09K8 2 months ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    Lifecycle approach could cut cell and gene therapy costs

  • BioProcess Insider

    WuXi Bio set for 430,000 L biomanufacturing capacity from 2024

  • BioProcess Insider

    Oravax launches to advance oral COVID-19 vaccines

  • BioProcess Insider

    Novartis exiting Longmont due to changing gene therapy capacity need

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2021 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    ▼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    ▼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    ▼
    • BioProcess International West
    • COVID-19 Therapeutic Development & Production
  • BioProcess International Academy
  • Events